Video

Shirley Lee on how practices can increase patient buy-in with their treatment

Author(s):

Urology Times staff

“We really need to listen to what people care about and speak to that,” says Shirley Lee, CRNP-FNP, MPH.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Shirley Lee, CRNP-FNP, discusses ways that busy practices can increase patient buy-in with treatment. Lee is director of a patient navigation program and a nurse practitioner for the Greater Los Angeles Division of Genesis Healthcare Partners and Vice President of Clinical Strategy for Preveta.

      Related Videos
      Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
      Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
      Sima Porten, MD, on gene-environment interactions in bladder cancer development
      Sima Porten, MD, on gene-environment interactions in bladder cancer development
      Naeem Bhojani, MD, expands on key findings from WATER III trial
      Naeem Bhojani, MD, expands on key findings from WATER III trial
      Hailey Frye answers a question during a Zoom video interview
      Hailey Frye discusses improvement of pain management for nephrolithiasis
      Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
      Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
      3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
      How rBCG EAP could open up access for Anktiva in bladder cancer
      Betty Wang, MD, discusses studies from the 2025 EAU meeting
      Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
      Neeraj Agarwal, MD, on the safety profile of talazoparib/enzalutamide in mCRPC
      Neeraj Agarwal, MD, on the safety profile of talazoparib/enzalutamide in mCRPC
      Anna Myers, CNP, answers a question during a Zoom video interview
      Anna Myers, CNP, discusses her approach to preventing UTIs
      Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
      Joshua J. Meeks, MD, PhD, discusses the impact of neoadjuvant durvalumab approval in MIBC
      Related Content
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      April 14th 2025

      Coding Q&A: How to bill for second-generation stone device

      Jonathan Rubenstein, MD Mark Painter
      Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.
      Health policy in urology: 2024 AUA Advocacy Summit recap
      March 21st 2024

      Health policy in urology: 2024 AUA Advocacy Summit recap

      Urology Times staff
      In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
      Closeup financial chart with uptrend line candlestick graph in stock market on blue color monitor background | Image Credit: © iamchamp - stock.adobe.com
      March 21st 2025

      Money Matters: How to cope with market volatility in 2025

      Jeff Witz, CFP
      "If you determine you can invest in a volatile environment, the best approach is to do so over a period of time," writes Jeff Witz, CFP.
      How APPs can bridge the gap in urologist shortages
      August 28th 2023

      How APPs can bridge the gap in urologist shortages

      Urology Times staff
      In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
      Two doctors being discussing patient history | Image Credit: © Freedomz - stock.adobe.com
      February 19th 2025

      Level of service for vasectomy prompts coding confusion

      Jonathan Rubenstein, MD Mark Painter
      "With the requirements for an E/M code as noted above, we agree with you that the supporting documentation, if appropriately documented, would support a level 3 outpatient visit for a visit regarding counseling for contraception or family planning," write Jonathan Rubenstein, MD, and Mark Painter.
      Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025
      February 10th 2025

      Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

      Arpeet Shah, MD
      Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.
      © 2025 MJH Life Sciences

      All rights reserved.